Ke Zhang

Professor Ke Zhang is researching a new drug delivery method using oligonucleotides to treat Duchenne Muscular Dystrophy (DMD), with potential applications in other genetic diseases, offering hope for more efficient treatments.

Ke Zhang

Affiliated Faculty,  Bioengineering
Associate Professor,  Chemistry and Chemical Biology